NOVACYT
The Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in diagnostics product development, commercialisation, contract design and manufacturing. The Company’s lead business units comprise of Primerdesign and Lab21 Products, supplying an extensive range of high quality assays and reagents worldwide. The Group directly serves oncology, microbiology, haematology and serology markets as do its global partners, which include major corporates.
NOVACYT
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2006-01-01
Address:
Vélizy-villacoublay, Ile-de-France, France
Country:
France
Website Url:
http://www.novacyt.com
Total Employee:
101+
Status:
Active
Contact:
+330139465104
Total Funding:
37.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-15 | IT-IS International | IT-IS International acquired by NOVACYT | 10.1 M GBP |
| 2016-01-18 | Primer Design | Primer Design acquired by NOVACYT | 17.6 M USD |
| 2014-06-05 | Lab21 | Lab21 acquired by NOVACYT | 40 M EUR |
| 2013-02-28 | Centre de Compétences International en Tele-Imagerie | Centre de Compétences International en Tele-Imagerie acquired by NOVACYT | N/A |
Investors List
Kreos Capital
Kreos Capital investment in Post-IPO Debt - NOVACYT
YA Global Master SPV
YA Global Master SPV investment in Post-IPO Debt - NOVACYT
Alto Invest
Alto Invest investment in Venture Round - NOVACYT
Arkeon Gestion
Arkeon Gestion investment in Venture Round - NOVACYT
Official Site Inspections
http://www.novacyt.com Semrush global rank: 5.02 M Semrush visits lastest month: 1.66 K
- Host name: 104.21.52.2
- IP address: 104.21.52.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NOVACYT"
Home | Novacyt Group
Global provider of molecular assays and instrumentation to positively impact scientific advances. Novacyt is an international molecular diagnostics company providing a broad portfolio of …See details»
About Us - Novacyt
Learn about Novacyt, a leader in diagnostics, committed to enhancing global healthcare through innovative testing solutions.See details»
What We Do | Novacyt
Novacyt is an international molecular diagnostics company providing a broad portfolio of integrated technologies and services, primarily focused on the delivery of genomic medicine.See details»
Novacyt - Wikipedia
Novacyt Group (/ ˈ n oÊŠ v É™ s aɪ t / NOH-vÉ™-syte) is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy …See details»
NOVACYT - Crunchbase Company Profile & Funding
The Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in …See details»
Novacyt Group - LinkedIn
The Novacyt Group is an international molecular diagnostics group, including Yourgene Health and Primerdesign companies | At Novacyt, we pride ourselves on concentrating our expertise on...See details»
Clinical diagnostics revolution set to boost patient …
Sep 22, 2021 · Novacyt’s growing ability to run clinical trials, and its in-house regulatory expertise, have been lynchpins of the company’s pandemic response. Our integrated approach combines regulatory, discovery and development …See details»
Novacyt Careers - Novacyt Careers
The Novacyt Group of companies includes Primerdesign, Y ourgene Health and MyGo (IT-IS International) – creating a stronger, global diagnostics business. The companies work together to develop new innovative diagnostic solutions to …See details»
Executive Leadership Team | Novacyt
Meet Novacyt's executive leadership team, driving innovation in diagnostics and leading the company to new heights in healthcare.See details»
Novacyt S.A. ("Novacyt", the "Company" or the "Group")
Jan 25, 2022 · We remain committed to becoming a leading, global clinical diagnostics company in the fight against infectious diseases, which will be enabled by strengthening the team, our …See details»
Novacyt is powering ahead and tackling emerging …
May 31, 2022 · Close partnerships with the World Health Organization and UNICEF, plus its own bio surveillance and ongoing research, give Novacyt the foresight to anticipate future need in a world with evolving health challenges.See details»
Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Full year …
Apr 28, 2022 · The Novacyt Group is an international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in …See details»
Novacyt SA, NCYT:LSE profile - FT.com - Financial Times
6 days ago · Novacyt SA (NCYT:LSE) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Novacyt Group - YouTube
Novacyt, a world-renowned diagnostics business, offering a portfolio of invitro diagnostic tests, supporting healthcare across the globe. The genesig q16 is a revolutionary instrument …See details»
Our History | Novacyt
Novacyt is an international molecular diagnostics company providing a broad portfolio of integrated technologies and services, primarily focused on the delivery of genomic medicine.See details»
Novacyt S.A.: Research and Development Update - Business Wire
Feb 24, 2021 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on the progress of its near-term research and …See details»
Investors - Novacyt
Access the latest investor information for Novacyt, including financial reports, shareholder updates, and market insights.See details»
Novacyt S.A.: Full Year 2020 Results and Update on Growth Strategy
Jun 22, 2021 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) ("Novacyt", the "Company" or the "Group"), an international specialist in clinical diagnostics, announces its audited results …See details»
Global bioinformatics surveillance: SARS-CoV-2 variant detection …
May 17, 2021 · Novacyt’s bioinformatics surveillance group has worked with a global network of virologists tracking variants to identify the mutations expected to pose the greatest challenges …See details»
Contact Us - Novacyt
Get in touch with Novacyts team for enquiries and support. Visit our contact page for more information and assistance.See details»